Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion

Completed · Not applicable

Conditions studied: Termination of Pregnancy

In brief

This study will test ways to give women more options and flexibility when they are ending their unwanted pregnancies. The investigators will look at uptake and acceptability of using mifepristone outside of the clinic for pregnancy termination.

Key facts

Study ID

NCT01811056

Run by

Gynuity Health Projects

People needed

401

Starts

2013-04-01

Expected to finish

2014-07-01

Last updated by the study team

2015-08-13

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women 18 years and older
• seeking medical abortion services
• in general good health
• assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken
• eligible for medical abortion according to clinician and center standards.

You may not qualify if…

• will be followed up by beta HCG and not ultrasound

Where it is running

• Planned Parenthood of New York City — New York, New York, United States
• Planned Parenthood of Northern New England — Barre, Burlington, Rutland, Vermont, United States
• Planned Parenthood of the Great Northwest — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.